Obesity presents a growing challenge for the population and for services, and prescribing now plays an important role alongside lifestyle and behavioural interventions. In this session, Hannah Beba (Consultant Pharmacist for Diabetes and Clinical Lead for Obesity) explored when and for whom obesity medicines are appropriate, how to integrate them safely and effectively into routine care, and how to embed this within ongoing quality improvement and audit. The session focused on practical prescribing, monitoring and review, using data and audit findings to refine local pathways and support sustainable weight loss and improved cardiometabolic outcomes.
